Nauzene

Manufacturer: Alva-Amco Pharmacal Companies, Inc.
Effective date: 2010-05-07
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: full-release
Hydrated at: 2026-05-31 22:24:26

Label at a glance#

ProductNauzene

Active ingredientTRISODIUM CITRATE DIHYDRATE, Dextrose, Fructose

Label structure14 sections

Indications and uses

For the relief of nausea associated with upset stomach, including that due to overindulgence in food or drink.

Dosage and administration

Read all package directions and warnings before use and use only as directed. Adults: 1 - 2 tablespoons (15 - 30 mL). Children: Consult a doctor for appropriate dosage. Dosage may be repeated after 30 minutes not to exceed 6 doses in a 24-hour period unless advised by a doctor. For maximum effectiveness never dilute Nauzene or drink fluids of any kind immediately before or after taking Nauzene. Nauzene Liquid is...

Contacts and useful links#

PhoneLabel contact1-800-792-2582

Label contents#

Full prescribing information#

Active ingredients (in each 15-mL tablespoon)

OTC - ACTIVE INGREDIENT SECTION

Dextrose (glucose) 4.35 g...........................anti-nausea

Levulose (fructose) 4.17 g...........................anti-nausea

Sodium citrate dihydrate, 0.921 g................antacid

Uses

OTC - PURPOSE SECTION

For the relief of nausea associated with upset stomach, including that due to overindulgence in food or drink.

OTC - DO NOT USE SECTION

Do not use if you have Hereditary Fructose Intolerance (HFI). This product contains fructose.

Ask a doctor before use if you

OTC - ASK DOCTOR SECTION

you have diabetes because this product contains sugar
are on a sodium-restricted diet.

OTC - ASK DOCTOR/PHARMACIST SECTION

Ask a doctor or pharmacist before use if you are taking any other medications. Antacids may interact with certain prescription drugs.

OTC - WHEN USING SECTION

When using this product do not take more than 6 does in a 24-hour period.

OTC - STOP USE SECTION

Stop use and ask a doctor if nausea lasts more than two weeks or recurs frequently.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breastfeeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Read all package directions and warnings before use and use only as directed.
Adults: 1 - 2 tablespoons (15 - 30 mL).
Children: Consult a doctor for appropriate dosage.
Dosage may be repeated after 30 minutes not to exceed 6 doses in a 24-hour period unless advised by a doctor.
For maximum effectiveness never dilute Nauzene or drink fluids of any kind immediately before or after taking Nauzene.
Nauzene Liquid is intended for use by normally healthy persons only.
Persons under 18 years of age should use only as directed by a doctor.

Other information

INFORMATION FOR PATIENTS SECTION

Sodium content 193 mg/tablespoon (15 mL).
Store at room temperature.
** Contents sealed: Each bottle of Nauzene Liquid has a tamper evident seal around the cap and a safety seal under the cap. Do not use if either of these seals appears broken. NOTE: Nauzene is not intended as a substitute for a balanced nutritional diet or as an electrolyte replenishment.
Serious side effects associated with the use of this product may be reported to the phone number provided below.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Corn syrup, FDC Red No. 40 lake, flavor, fructose syrup, glycerin, methylparaben, phosphoric acid, purified water.

OTC - QUESTIONS SECTION

Questions? 1-800-792-2582

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Nauzene Liquid PDP

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	SPL version
895045	glucose 4.35 GM / fructose 4.17 GM / sodium citrate 0.921 GM in 15 mL Oral Solution	PSN	2
895045	fructose 278 MG/ML / glucose 290 MG/ML / sodium citrate 61.4 MG/ML Oral Solution	SCD	2
895045	fructose 4.17 GM / glucose 4.35 GM / sodium citrate 0.921 GM per 15 ML Oral Solution	SY	2

DailyMed Pharmacologic Classes#

Class, Version, Type table
Class	Version	Type	Effective
ANHYDROUS CITRIC ACID Pharmacologic Class Indexing	3	Indexing - Pharmacologic Class	20180813

Product Linked Resources#

Resource, Code type, Value table
Resource	Code type	Value	Equivalent identifiers	Source image
Barcode	EAN-13	0072959720049	GTIN-13: 0072959720049 EAN-13: 0072959720049 GTIN-12: 072959720049 UPC-A: 072959720049 GTIN storage (14 digits): 00072959720049	NauzeneLiquidPDP.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
52389-172-04	2020-01-31	C162847	48780-1	9d75b9cf-d79c-f424-e053-dadaa90a57ce	Drug Facts

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
52389-172-04	Nauzene	118 mL in 1 BOTTLE, PLASTIC	SYRUP	118		2

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
52389-172	NAUZENE (SODIUM CITRATE) SYRUP [ALVA-AMCO PHARMACAL COMPANIES, INC.]	2	Legacy NDC, 1 package rows	20100507_728376f5-6cab-404e-b519-f6c595291d6f.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
Dextrose	ACTIVE INGREDIENT	IY9XDZ35W2	2
Fructose	ACTIVE INGREDIENT	6YSS42VSEV	2
TRISODIUM CITRATE DIHYDRATE	ACTIVE INGREDIENT	B22547B95K	2
ANHYDROUS CITRIC ACID	ACTIVE MOIETY	XF417D3PSL	2
Dextrose	ACTIVE MOIETY	IY9XDZ35W2	2
Fructose	ACTIVE MOIETY	6YSS42VSEV	2
corn syrup	INACTIVE INGREDIENT	9G5L16BK6N	2
FD&C Red No. 40	INACTIVE INGREDIENT	WZB9127XOA	2
Glycerin	INACTIVE INGREDIENT	PDC6A3C0OX	2
High fructose corn syrup	INACTIVE INGREDIENT	XY6UN3QB6S	2
Methylparaben	INACTIVE INGREDIENT	A2I8C7HI9T	2
Phosphoric acid	INACTIVE INGREDIENT	E4GA8884NN	2
Water	INACTIVE INGREDIENT	059QF0KO0R	2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

Nauzene
Sodium Citrate
TRISODIUM CITRATE DIHYDRATE
ANHYDROUS CITRIC ACID
Dextrose
Fructose
corn syrup
FD&C Red No. 40
High fructose corn syrup
Glycerin
Methylparaben
Phosphoric acid
Water

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
52389-172	52389-172-04

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 10 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
TRISODIUM CITRATE DIHYDRATE	B22547B95K	ACTIB
Dextrose	IY9XDZ35W2	ACTIB
Fructose	6YSS42VSEV	ACTIB
corn syrup	9G5L16BK6N	IACT
FD&C Red No. 40	WZB9127XOA	IACT
High fructose corn syrup	XY6UN3QB6S	IACT
Glycerin	PDC6A3C0OX	IACT
Methylparaben	A2I8C7HI9T	IACT
Phosphoric acid	E4GA8884NN	IACT
Water	059QF0KO0R	IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 4 · 223 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
Methylparaben	METHYLPARABEN	A2I8C7HI9T	JELLY / NASAL	250 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
Glycerin	GLYCERIN	PDC6A3C0OX	INJECTION / INTRAMUSCULAR		450 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
Glycerin	GLYCERIN	PDC6A3C0OX	FILM, EXTENDED RELEASE / BUCCAL		34 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
High fructose corn syrup	HIGH FRUCTOSE CORN SYRUP	XY6UN3QB6S	SUSPENSION, EXTENDED RELEASE / ORAL		3000 mg	Exact identifier — unii candidate 3 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	SOLUTION / NASAL	250 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
Glycerin	GLYCERIN	PDC6A3C0OX	SUSPENSION / ORAL		26208 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
Phosphoric acid	PHOSPHORIC ACID	E4GA8884NN	CREAM / VAGINAL	0.56 %w/w		Exact identifier — unii candidate 28 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	SOLUTION / IRRIGATION	2 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	SOLUTION / INTRAMUSCULAR	0.13 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
Glycerin	GLYCERIN	PDC6A3C0OX	TABLET, COATED / ORAL	1 mg		Exact identifier — unii candidate 75 equally ranked IID candidates
Phosphoric acid	PHOSPHORIC ACID	E4GA8884NN	CREAM / TOPICAL		13 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
Glycerin	GLYCERIN	PDC6A3C0OX	LIQUID / ORAL		2400 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	POWDER, FOR SUSPENSION / ORAL		75 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	ENEMA / RECTAL	0.18 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	CAPSULE / ORAL		7 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
FD&C Red No. 40	FD&C RED NO. 40	WZB9127XOA	CAPSULE, LIQUID FILLED / ORAL		1 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
Phosphoric acid	PHOSPHORIC ACID	E4GA8884NN	INJECTION, SOLUTION / INTRAVENOUS	ADJ PH		Exact identifier — unii candidate 28 equally ranked IID candidates
Glycerin	GLYCERIN	PDC6A3C0OX	DOUCHE / VAGINAL	1 %w/w		Exact identifier — unii candidate 75 equally ranked IID candidates
Phosphoric acid	PHOSPHORIC ACID	E4GA8884NN	SOLUTION / TOPICAL	0.23 %w/w		Exact identifier — unii candidate 28 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	CREAM, AUGMENTED / TOPICAL		2 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	CREAM / VAGINAL		22 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
FD&C Red No. 40	FD&C RED NO. 40	WZB9127XOA	SYRUP / ORAL		3 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
Phosphoric acid	PHOSPHORIC ACID	E4GA8884NN	SOLUTION/ DROPS / OPHTHALMIC	ADJ PH		Exact identifier — unii candidate 28 equally ranked IID candidates
Glycerin	GLYCERIN	PDC6A3C0OX	GEL / OPHTHALMIC	0.88 %w/w		Exact identifier — unii candidate 75 equally ranked IID candidates
Glycerin	GLYCERIN	PDC6A3C0OX	INJECTION, SOLUTION / SUBCUTANEOUS	15 %w/v		Exact identifier — unii candidate 75 equally ranked IID candidates
Glycerin	GLYCERIN	PDC6A3C0OX	EMULSION / OPHTHALMIC		3 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	SOLUTION/ DROPS / OPHTHALMIC	0.05 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
Phosphoric acid	PHOSPHORIC ACID	E4GA8884NN	INJECTION / INTRA-ARTICULAR	ADJ PH		Exact identifier — unii candidate 28 equally ranked IID candidates
Glycerin	GLYCERIN	PDC6A3C0OX	SOLUTION, CONCENTRATE / ORAL	200 mg/1ml		Exact identifier — unii candidate 75 equally ranked IID candidates
Phosphoric acid	PHOSPHORIC ACID	E4GA8884NN	LOTION, AUGMENTED / TOPICAL		1 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	EMULSION / TOPICAL	0.2 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	ELIXIR / ORAL	800 mg		Exact identifier — unii candidate 79 equally ranked IID candidates
Phosphoric acid	PHOSPHORIC ACID	E4GA8884NN	INJECTION / SOFT TISSUE	ADJ PH		Exact identifier — unii candidate 28 equally ranked IID candidates
FD&C Red No. 40	FD&C RED NO. 40	WZB9127XOA	DROPS / ORAL	NA		Exact identifier — unii candidate 28 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	INJECTION / INTRA-ARTICULAR	0.24 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
FD&C Red No. 40	FD&C RED NO. 40	WZB9127XOA	POWDER, FOR SUSPENSION / ORAL		3 mg	Exact identifier — unii candidate 28 equally ranked IID candidates
FD&C Red No. 40	FD&C RED NO. 40	WZB9127XOA	TABLET, EXTENDED RELEASE / ORAL	2.22 mg		Exact identifier — unii candidate 28 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	INJECTION / INTRALESIONAL	0.15 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	SOLUTION / OPHTHALMIC	0.05 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	GEL / VAGINAL		8 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
Glycerin	GLYCERIN	PDC6A3C0OX	INJECTION, SOLUTION / INTRAMUSCULAR	15 %w/v		Exact identifier — unii candidate 75 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	SUSPENSION/ DROPS / OPHTHALMIC	0.05 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
FD&C Red No. 40	FD&C RED NO. 40	WZB9127XOA	SPONGE / TOPICAL	NA		Exact identifier — unii candidate 28 equally ranked IID candidates
corn syrup	CORN SYRUP	9G5L16BK6N	ELIXIR / ORAL	400 mg/1ml		Exact identifier — unii candidate 10 equally ranked IID candidates
High fructose corn syrup	HIGH FRUCTOSE CORN SYRUP	XY6UN3QB6S	SOLUTION / ORAL		10000 mg	Exact identifier — unii candidate 3 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	INJECTION / SOFT TISSUE	0.15 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	SYSTEM / TOPICAL		42 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
Glycerin	GLYCERIN	PDC6A3C0OX	CAPSULE, EXTENDED RELEASE / ORAL		265 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	SYRUP / ORAL		81 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	OINTMENT / OPHTHALMIC	0.05 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
FD&C Red No. 40	FD&C RED NO. 40	WZB9127XOA	CAPSULE, COATED PELLETS / ORAL	NA		Exact identifier — unii candidate 28 equally ranked IID candidates
Phosphoric acid	PHOSPHORIC ACID	E4GA8884NN	INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR	ADJ PH		Exact identifier — unii candidate 28 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	SUSPENSION / RECTAL		1808 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
Phosphoric acid	PHOSPHORIC ACID	E4GA8884NN	INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS	ADJ PH		Exact identifier — unii candidate 28 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	INJECTION / INTRAMUSCULAR		95 mg	Exact identifier — unii candidate 79 equally ranked IID candidates
Glycerin	GLYCERIN	PDC6A3C0OX	TABLET / PERIODONTAL	0.53 mg		Exact identifier — unii candidate 75 equally ranked IID candidates
Glycerin	GLYCERIN	PDC6A3C0OX	SYRUP / ORAL		16734 mg	Exact identifier — unii candidate 75 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	SHAMPOO / TOPICAL	0.15 %w/w		Exact identifier — unii candidate 79 equally ranked IID candidates
Methylparaben	METHYLPARABEN	A2I8C7HI9T	SOLUTION / INTRAVENOUS	0.13 %w/v		Exact identifier — unii candidate 79 equally ranked IID candidates
Glycerin	GLYCERIN	PDC6A3C0OX	SOLUTION / OPHTHALMIC	6 %w/v		Exact identifier — unii candidate 75 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
b35b5e0f-9b2e-40ae-9db7-65f245e40844			728376f5-6cab-404e-b519-f6c595291d6f	2010-05-07	Warnings	Exact identifier spl id: b35b5e0f-9b2e-40ae-9db7-65f245e40844 spl set id: 728376f5-6cab-404e-b519-f6c595291d6f

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.